Table 3.

Priorities for pancreatic cancer: surgical oncology and image-guided surgical procedures

High priority	Medium priority	Low priority
Resectable cancers (primary or after neoadjuvant treatment) including resectable cystic lesions with suspicion of malignancy	Hepatojejunostomy (or hepatogastrojejunostomy in case of gastric obstruction) in case of biliary obstruction and recurrent cholangitis in patients with non-resectable localised or metastatic disease, good PS and life expectancy >3 months
Borderline cancers in patients not fit for neoadjuvant treatment	Duodenal stent and/or PEG tubes in case of gastroduodenobiliary obstruction in symptomatic patients in BSC
Endoscopic placement of biliary stent in case of biliary obstruction in non-resectable or metastatic cancers
Endoscopic placement of biliary stent in case of biliary obstruction: in resectable cancers with active cholangitis and bilirubin >250 µmol, or non-resectable localised cancers assigned to neoadjuvant or palliative treatment
Post-surgery complications (anastomotic leak, bleeding, acute pancreatitis, fistulae)
Histologic assessment: CT scan or EUS guided in case of urgent therapeutic consequences such as curative resection or symptom relief

BSC, best supportive care; EUS, endoscopic ultrasound; PEG, percutaneous endoscopic gastrostomy; PS, performance status.